Big insurers remain upbeat about fledgling ACA exchanges
Slipping enrollment has done little to shake the faith that the nation's biggest health insurers, including Anthem, have placed in the Affordable Care Act's public insurance exchanges.
Elevance
Articles
Surge of new customers boosts Anthem’s profit
Anthem’s third-quarter profit rose nearly 4 percent as it added 174,000 health plan members. Its Medicaid, local employer and national employer segments all grew, although its individual business saw losses.
Anthem shares sliding after Clinton calls for merger review
Shares in Anthem Inc. and Cigna Corp., which agreed to a $48 billion deal in July, continued to slide Thursday after presidential candidate Hillary Clinton said mergers in the industry deserve more scrutiny.
Clinton skeptical that Anthem-Cigna merger would benefit consumers
Presidential candidate Hillary Rodham Clinton warned Wednesday that the planned $48B deal could stifle competition between health insurers, including in the early battleground state of New Hampshire.
Anthem, Aetna defend acquisitions called harmful by hospitals
Anthem Inc. CEO Joseph Swedish and Aetna Inc. CEO Mark Bertolini will tell federal lawmakers Tuesday that the deals are necessary to succeed in a changing health-care landscape.
Indiana’s least competitive places to buy health insurance
Four of the 10 metro areas that will see the biggest decrease in competition from the Anthem-Cigna merger are in Indiana, according to an analysis by the American Medical Association—with Indianapolis facing the second-biggest impact among all of Anthem’s markets nationwide.
AMA: Anthem, Aetna deals threaten competition across nation
The market for health-insurance in the U.S. is already so highly concentrated that pending tie-ups among four of the country’s largest insurers risk hurting both consumers and doctors, the American Medical Association said.
Anthem to cover libido pill; other insurers weighing decision
Concerns about serious side effects, including fainting, complicate discussions about whether to cover Sprout Pharmaceuticals' Addyi.
Anthem-Cigna mega deal might snag on Blue Cross
Anthem Inc. has used the Blue Cross and Blue Shield brand names as a powerful tool on its way to becoming the nation’s second-largest health insurer. But those Blue brands now are a hurdle for Anthem’s $54.2 billion acquisition of Cigna Corp.
Mega-mergers pressure small health insurance plans
Mega-mergers among Anthem Inc. and its fellow health insurance giants could put pressure on provider-owned health plans such as Advantage Health Solutions and Indiana University Health Plans.
Anthem’s second-quarter profit surges past analyst expectations
Indianapolis-based Anthem Inc. reported Wednesday morning that it earned $859.1 million during the three months ended June 30, an increase of 17.5 percent over the same quarter of 2014.
Anthem gets $26.5B funding commitment for Cigna takeover
Anthem Inc.’s bid to become the largest health insurer in history is setting up one of the biggest debt offerings backing a takeover.
Health insurer deal fever may spread to hospitals next
Seeing mergers like Anthem’s planned acquisition of Cigna Corp., hospitals could decide that striking deals of their own could improve their negotiating power over medical reimbursements.
City dodges bullet as HQ stays under Anthem-Cigna deal
The company says its corporate headquarters will remain in Indianapolis, where its operations are responsible for contributing millions of dollars in corporate taxes and charitable giving.
FROM THE ARCHIVES: Anthem’s path from laggard to leader
This 1992 profile of then-CEO L. Ben Lytle chronicles the evolution of the company—then known as The Associated Group—from a sleepy health insurer operating in only one state into an acquisitive, aggressive business with national ambitions.
Anthem to buy Cigna in $54B deal
After a long and stormy courtship, Anthem Inc. announced Friday morning that it will pay $188 per share to acquire Cigna Corp., valuing the deal at $54.2 billion in cash, stock and the assumption of debt.
Lilly, Anthem show high risk, high reward strategy can pay off
The CEOs of Eli Lilly and Anthem are being rewarded by investors for taking high-risk approaches to develop breakthrough drugs, make major acquisitions.
Anthem’s next challenge: getting regulators to say OK
The next challenge for Anthem Inc. in its quest to marry Cigna Corp. is to get its legal guardians to allow the ceremony to happen.
Indy’s top 11 acquisition deals, before Anthem-Cigna
Anthem’s $54 billion bid for rival insurer Cigna is twice the size of the next-largest acquisition in the Indianapolis area, which occurred nearly a decade ago.
Investors still cautious about antitrust scrutiny on Anthem-Cigna deal
The stock price for Cigna Corp. remained lethargic during trading Thursday, as another mega-merger of insurers complicated the Anthem deal and sparked antitrust concerns.